Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 51 results
May 2017
-
In The NewsNovartis Access and government of Pakistan sign memorandum of understandingNovartis reaches agreement with Pakistan to increase access to medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
-
In The NewsNovartis Access perspective: The key to fighting chronic disease in South-East Asia - young peopleHarald Nusser, Head of Novartis Social Business, explains why educating young people is key to fighting chronic disease in South-East Asia.
-
In The NewsNovartis Access perspective: How smart partnerships can help us fight chronic disease in AfricaHarald Nusser, Head of Novartis Social Business, talks about how the pharmaceutical industry can work with partners to overcome access issues in poor countries.
March 2017
-
In The NewsWorld Malaria Report 2016: keeping up the momentumHarald Nusser, Head of Novartis Social Business shares his insights from the launch of the World Malaria report 2016 in London.
-
In The NewsAt a Juncture in Malaria EradicationHarald Nusser, Head of Novartis Social Business reflects on the chance of reaching a malaria-free world within our generation.
-
In The NewsWhat is really driving malaria control is the personal accountability and passion of community health workersHarald Nusser, Head of Novartis Social Business shares his insights following the latest National Malaria Control Program best practice sharing workshop in Dakar.
November 2016
-
In The NewsNew strategies for improving access in lower-income countriesHumanosphere highlights the work Novartis Access is doing to find a social enterprise solution to help patients in lower-income countries get access to medicines for chronic diseases.
-
In The NewsNovartis Access one-year reportThe Novartis Access one-year report describes first results, early learnings and challenges from our first twelve months on the ground. It also includes external perspectives and country updates,…
-
In The NewsTackling chronic disease with Novartis AccessChronic diseases like high blood pressure and diabetes impact more than just wealthy nations. Through the Novartis Foundation and Novartis Access, we’re working to address the rising threat of…
-
In The NewsThe price of drugs should reflect the value they deliverIn Forbes commentary, Novartis CEO says industry should focus on outcomes for patients and healthcare systems.